title: Protein kinase A-dependent neuronal nitric oxide synthase activation mediates the enhancement of baroreflex response by adrenomedullin in the nucleus tractus solitarii of rats.
abstract: BACKGROUND
  Adrenomedullin (ADM) exerts its biological functions through the receptor-mediated enzymatic mechanisms that involve protein kinase A (PKA), or neuronal nitric oxide synthase (nNOS). We previously demonstrated that the receptor-mediated cAMP/PKA pathway involves in ADM-enhanced baroreceptor reflex (BRR) response. It remains unclear whether ADM may enhance BRR response via activation of nNOS-dependent mechanism in the nucleus tractus solitarii (NTS).
  
  
  METHODS
  Intravenous injection of phenylephrine was administered to evoke the BRR before and at 10, 30, and 60 min after microinjection of the test agents into NTS of Sprague-Dawley rats. Western blotting analysis was used to measure the level and phosphorylation of proteins that involved in BRR-enhancing effects of ADM (0.2 pmol) in NTS. The colocalization of PKA and nNOS was examined by immunohistochemical staining and observed with a laser confocal microscope.
  
  
  RESULTS
  We found that ADM-induced enhancement of BRR response was blunted by microinjection of NPLA or Rp-8-Br-cGMP, a selective inhibitor of nNOS or protein kinase G (PKG) respectively, into NTS. Western blot analysis further revealed that ADM induced an increase in the protein level of PKG-I which could be attenuated by co-microinjection with the ADM receptor antagonist ADM22-52 or NPLA. Moreover, we observed an increase in phosphorylation at Ser1416 of nNOS at 10, 30, and 60 min after intra-NTS administration of ADM. As such, nNOS/PKG signaling may also account for the enhancing effect of ADM on BRR response. Interestingly, biochemical evidence further showed that ADM-induced increase of nNOS phosphorylation was prevented by co-microinjection with Rp-8-Br-cAMP, a PKA inhibitor. The possibility of PKA-dependent nNOS activation was substantiated by immunohistochemical demonstration of co-localization of PKA and nNOS in putative NTS neurons.
  
  
  CONCLUSIONS
  The novel finding of this study is that the signal transduction cascade that underlies the enhancement of BRR response by ADM in NTS is composed sequentially of cAMP/PKA and nNOS/PKG pathways.
authors: Institute of Emergency and Critical Care Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
authors: David H T
authors: DH
authors: Yen
authors: Lih-Chi
authors: LC
authors: Chen
authors: Yuh-Chiang
authors: YC
authors: Shen
authors: Ying-Chen
authors: YC
authors: Chiu
authors: I-Chun
authors: IC
authors: Ho
authors: Ya-Jou
authors: YJ
authors: Lou
authors: I-Chin
authors: IC
authors: Chen
authors: Jiin-Cherng
authors: JC
authors: Yen
references: Eur J Neurosci. 2001 Aug;14(4):618-28
references: 11556887
references: Peptides. 2001 Nov;22(11):1803-7
references: 11754966
references: Regul Pept. 2003 Apr 15;112(1-3):87-93
references: 12667629
references: J Biol Chem. 2001 Dec 28;276(52):49459-65
references: 11591721
references: Biochem Biophys Res Commun. 1994 Apr 15;200(1):642-6
references: 8166740
references: Prog Neurobiol. 2001 May;64(1):51-68
references: 11250062
references: Neuroscience. 2009 Mar 17;159(2):727-34
references: 19167463
references: Brain Res. 2000 Jan 24;853(2):245-68
references: 10640622
references: Rev Physiol Biochem Pharmacol. 1981;88:24-124
references: 7010509
references: Br J Pharmacol. 2006 May;148(1):70-7
references: 16501581
references: Nitric Oxide. 2009 Jun;20(4):223-30
references: 19298861
references: Neuropharmacology. 2008 Oct;55(5):729-36
references: 18616957
references: Am J Hypertens. 1994 May;7(5):478-82
references: 8060585
references: J Pharmacol Exp Ther. 2007 May;321(2):455-61
references: 17283224
references: Neurosci Bull. 2009 Dec;25(6):325-34
references: 19927168
references: Biochem Biophys Res Commun. 1993 Apr 30;192(2):553-60
references: 8387282
references: Neurosci Lett. 1999 May 28;267(2):85-8
references: 10400218
references: Mol Pharmacol. 2004 Feb;65(2):319-25
references: 14742673
references: J Chem Neuroanat. 2005 Mar;29(2):127-36
references: 15652699
references: Circ Res. 2010 Mar 5;106(4):788-95
references: 20056918
references: FEBS Lett. 2001 May 18;497(1):65-6
references: 11376664
references: Mol Endocrinol. 2007 Apr;21(4):783-96
references: 17053041
references: J Biol Chem. 1999 Jul 16;274(29):20597-602
references: 10400690
references: Chin J Physiol. 1996;39(1):57-62
references: 8902305
references: Am J Physiol Regul Integr Comp Physiol. 2008 Nov;295(5):R1376-84
references: 18685068
references: Am J Physiol. 1996 Feb;270(2 Pt 2):H575-82
references: 8779833
references: Brain Res. 2007 Sep 26;1171:42-51
references: 17761150
references: Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H256-62
references: 15598868
references: Mol Pharmacol. 2007 Jul;72(1):112-20
references: 17446268
references: Neuropharmacology. 1999 Jul;38(7):935-41
references: 10428412
references: Am J Physiol Regul Integr Comp Physiol. 2008 Jul;295(1):R38-44
references: 18495835
references: Hypertension. 1999 Apr;33(4):992-7
references: 10205236
references: J Hypertens. 1998 Dec;16(12 Pt 2):1993-9
references: 9886888
references: Am J Physiol Regul Integr Comp Physiol. 2004 Oct;287(4):R729-34
references: 15178541
references: Hypertension. 2004 Apr;43(4):820-4
references: 14981065